Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Ricetec Inc. maintains 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 2 distinct examiners, though they are consolidated within 1 distinct art unit. KOVALENKO, MYKOLA V is identified as the busiest examiner for the portfolio, currently managing 1 pending office action.
The use of a single distinct art unit for the pending office actions suggests that while the examiners differ, the technical subject matter remains consistent within a specific USPTO division. With the assigned examiners involved, the portfolio experiences a variety of individual examination styles despite the unified art unit. The presence of the pending office action under KOVALENKO, MYKOLA V represents a significant portion of the current pending workload for the company. Practitioners can focus their analysis on the specific art unit's historical trends to anticipate future actions. This distribution requires balancing different examiner perspectives while adhering to the procedural standards of the assigned art unit. The concentration of filings in this technology area indicates a stable and specialized intellectual property strategy.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KOVALENKO, MYKOLA V | 1 | 69.5% | +25.8% |
| ZHONG, WAYNESHAOBIN | 1 | 72.2% | +21.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18457067 | EFFECTS OF A PLURALITY OF MUTATIONS TO IMPROVE HERBICIDE RESISTANCE/TOLERANCE IN RICE | KOVALENKO, MYKOLA V | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18457067 | EFFECTS OF A PLURALITY OF MUTATIONS TO IMPROVE HERBICIDE RESISTANCE/TOLERANCE IN RICE | KOVALENKO, MYKOLA V | — |
| 18295715 | HYBRID RICE RT23L401 | ZHONG, WAYNESHAOBIN | — |
| Art Unit | Apps |
|---|---|
| 1662 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18457067 | EFFECTS OF A PLURALITY OF MUTATIONS TO IMPROVE HERBICIDE RESISTANCE/TOLERANCE IN RICE | KOVALENKO, MYKOLA V | 1662 | §102§112 | Non-Final OA | — | Pending | Aug 28, 2023 |
| 18295715 | HYBRID RICE RT23L401 | ZHONG, WAYNESHAOBIN | 1662 | §112 | Non-Final OA | — | Pending | Apr 04, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial